Indivior Pharmaceuticals, Inc. (INDV) Profit Margins
Over the twelve months to 2026-06-30, Indivior Pharmaceuticals, Inc. (INDV) had gross margin 82.1%, operating margin 31.6%, net margin 26.7%, free cash flow margin -8.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
INDVIndivior Pharmaceuticals, Inc.Follow INDV — free
—
Price chart with a free account
- Market cap
- 4.1B
- P/E TTM
- 12.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | 84.1% | 80.6% | 80.2% | 82.1% | |
| Operating margin | -13.9% | 3.2% | 21.1% | 31.6% | |
| Net margin | -11.5% | 0.6% | 16.9% | 26.7% | |
| FCF margin | -28.2% | 0.6% | -7.5% | -8.3% |
USD billions · SEC XBRL
Indivior Pharmaceuticals, Inc. — questions
- What is Indivior Pharmaceuticals, Inc.'s gross margin?
- 82.1% over the twelve months to 2026-06-30.
- What is Indivior Pharmaceuticals, Inc.'s operating margin?
- 31.6% over the twelve months to 2026-06-30.
- What is Indivior Pharmaceuticals, Inc.'s net profit margin?
- 26.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Indivior Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.